Search - tctmd.com

Displaying 21 - 40 of 339

Sort: Relevancy | Date

PREDICT Offers a Heads-up on the Need for CT in Suspected Small Aortic Annuli

News Conference News EuroPCR 2025

PREDICT Offers a Heads-up on the Need for CT in Suspected Small Aortic Annuli

May 23, 2025

AI-ECG Helps Find Subclinical Heart Failure in Kenya

News Conference News ESC Heart Failure 2025

AI-ECG Helps Find Subclinical Heart Failure in Kenya

May 19, 2025

Higher CVD Risk in Children as Young as 10 Who Have Central Adiposity

News Conference News European Congress on Obesity 2025

Higher CVD Risk in Children as Young as 10 Who Have Central Adiposity

Michael O'Riordan

May 16, 2025

SELECT: Semaglutide’s Impact on CVD Events Emerges Quickly

News Conference News European Congress on Obesity 2025

SELECT: Semaglutide’s Impact on CVD Events Emerges Quickly

Michael O'Riordan

May 14, 2025

Studies Spotlight Safety Concerns With Pulsed-Field Ablation for AF

News Conference News HRS 2025

Studies Spotlight Safety Concerns With Pulsed-Field Ablation for AF

May 05, 2025

High-Sensitivity Troponin Tests Might Aid in Primary Prevention

News Daily News

High-Sensitivity Troponin Tests Might Aid in Primary Prevention

Yael L. Maxwell

April 16, 2025

ALPACA: Injectable siRNA Agent Safe and Effective for Lowering Lp(a)

News Conference News ACC 2025

ALPACA: Injectable siRNA Agent Safe and Effective for Lowering Lp(a)

April 10, 2025

AI Shows Promise in Detecting Type 1 MI and Need for Revascularization

News Conference News ACC 2025

AI Shows Promise in Detecting Type 1 MI and Need for Revascularization

Yael L. Maxwell

April 07, 2025

Pulsed-Field Ablation Equals, and May Top, Cryoablation for Paroxysmal AF

News Conference News EHRA 2025

Pulsed-Field Ablation Equals, and May Top, Cryoablation for Paroxysmal AF

March 31, 2025

SOUL: Oral Semaglutide Bests Usual Care in High-Risk Type 2 Diabetes

News Conference News ACC 2025

SOUL: Oral Semaglutide Bests Usual Care in High-Risk Type 2 Diabetes

Michael O'Riordan

March 29, 2025

Biomarker-Based Risk Score Better Predicts Stroke in AF Than Clinical Tools

News Daily News

Biomarker-Based Risk Score Better Predicts Stroke in AF Than Clinical Tools

March 19, 2025

Olpasiran Cuts Lp(a) but Not Inflammatory Markers: OCEAN(a)-DOSE

News Daily News

Olpasiran Cuts Lp(a) but Not Inflammatory Markers: OCEAN(a)-DOSE

Yael L. Maxwell

February 14, 2025

High-Sensitivity Troponin Assays Not All the Same, APACE Data Confirm

News Daily News

High-Sensitivity Troponin Assays Not All the Same, APACE Data Confirm

January 27, 2025

Top General Cardiology and Prevention News of 2024

News Daily News

Top General Cardiology and Prevention News of 2024

December 30, 2024

Teens Who Smoke Face Risk of Cardiac Damage by Their Mid-20s

News Daily News

Teens Who Smoke Face Risk of Cardiac Damage by Their Mid-20s

December 12, 2024

ARNI Lessens Anthracycline Cardiotoxicity in High-Risk Patients: SARAH

News Conference News AHA 2024

ARNI Lessens Anthracycline Cardiotoxicity in High-Risk Patients: SARAH

November 18, 2024

SUMMIT: Tirzepatide ‘Huge Win’ for HFpEF Patients With Obesity

News Conference News AHA 2024

SUMMIT: Tirzepatide a ‘Huge Win’ for HFpEF Patients With Obesity

Michael O'Riordan

November 16, 2024

TCT 719: Coronary Microvascular Resistance and High Sensitivity Troponin After Elective Percutaneous Coronary Intervention

Presentation TCT 2024

TCT 719: Coronary Microvascular Resistance and High Sensitivity Troponin After Elective Percutaneous Coronary Intervention

Presenter: Danilo Maksud

October 30, 2024

EVOLVED: Early AVR Fails to Help Asymptomatic AS Patients With Fibrosis

News Conference News TCT 2024

EVOLVED: Early AVR Fails to Help Asymptomatic AS Patients With Fibrosis

Michael O'Riordan

October 28, 2024

Semaglutide Helps in HFpEF Irrespective of Frailty, Exercise Capacity

News Conference News HFSA 2024

Semaglutide Helps in HFpEF Irrespective of Frailty, Exercise Capacity

October 01, 2024

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.